Small-cap value has done something in 2026 that few investors positioned for: it pulled meaningfully ahead of the growth complex that defined the prior decade. The thesis here is that small value beat large growth by roughly 9 percentage points year to date as the Magnificent 7 narrative broke down, and three ETFs have captured that premium more cleanly than the rest. Avantis U.S. Small Cap Value ETF (NYSEARCA:AVUV | AVUV Price Prediction), Vanguard Small-Cap Value ETF (NYSEARCA:VBR), and iShares S&P Small-Cap 600 Value ETF (NYSEARCA:IJS) each offer a distinct mechanism for harvesting the same factor premium.
The three funds operate differently: one is an actively managed academic factor tilt, one is a low-cost passive cap-weighted slice, and one rides on top of an index that already screens for profitability. Their 2026 returns reflect those differences directly.
Why the Small-Cap Value Trade Worked in 2026
The setup matters because it explains why these three funds, not a generic Russell 2000 product, captured the premium. JPMorgan’s 2026 outlook flagged that 2026 Magnificent 7 earnings growth was projected near 20%, compared with 11% for the S&P 493, leaving the rest of the index priced for far more than it was delivering. Morningstar made a related point in its 2026 global outlook, noting that the top 10 US stocks now account for over a third of the market, up from 18% a decade ago, and recommending that investors diversify into US small caps trading at a discount to fair value with far less AI exposure.
The rotation showed up cleanly in the small-cap tape. The Russell 2000 returned roughly 15% year-to-date through June 2, and small-cap growth via the iShares Russell 2000 Growth ETF returned about 17%. Within small caps, value barely separated from growth on the broad measures. The premium showed up in the funds with the strongest profitability and value screens, which is why fund selection matters more than usual this cycle.
Avantis U.S. Small Cap Value ETF (AVUV): The Standout
AVUV is the strongest fit for the 2026 thesis and the strongest performer on the list. The fund returned 18% year-to-date and 38% over the trailing year, outperforming both the Russell 2000 and the S&P 600 value benchmarks. The mechanism is the fund’s active overlay: rather than buying a static index of low price-to-book names, the Avantis team weights toward small-cap companies that combine cheap valuations with high profitability and stable cash generation, the academic factor combination associated with persistent premiums.
The portfolio holds more than 500 names with no position larger than about 1% of assets. Top holdings include Viasat, Matson, Lear, SM Energy, Avnet, Macy’s, StoneX Group, Five Below, and Cabot Corporation as a mix of profitable industrials, energy, transportation, and consumer names that rarely appear in growth indexes. AUM reached roughly $27 billion, reflecting heavy inflows as the factor delivered.
The trade-off is structural: AVUV is actively managed, so its expense ratio is higher than that of pure passive options, and its tilt toward smaller, deeper-value names creates more downside volatility than a broader fund. Investors who want the factor premium in its purest form pay for that exposure in both fees and tracking error against the broad market.
iShares S&P Small-Cap 600 Value ETF (IJS): The Quality-Screened Alternative
IJS belongs on the list because of what its parent index excludes. The S&P SmallCap 600 requires positive trailing earnings for inclusion, meaning IJS starts with a universe in which unprofitable small caps have already been screened out before the value overlay is applied. The fund returned 15% year-to-date and 39% over the trailing year, capturing most of the value premium without the active management costs.
The portfolio reflects classic small-cap value sector weights, led by Financials at roughly 23%, Consumer Discretionary at 15%, Industrials at 15%, Technology at 10%, and Materials at 6%. Top positions include Eastman Chemical, LKQ, Match Group, Celanese, SM Energy, Molina Healthcare, Paycom, CarMax, and Lamb Weston. The fund’s cost and scale profile rounds out the picture, with an expense ratio of 18 basis points, roughly $8.24 billion in assets, and a dividend yield near 1.29%.
The tradeoff is depth versus discipline. IJS gives up some of AVUV’s bottom-tier microcap exposure and active profitability scoring, but it costs a fraction as much to own and tracks an index with a transparent inclusion rule that has historically produced its own premium over broader small-cap benchmarks.
Vanguard Small-Cap Value ETF (VBR): The Cheap Broad Slice
VBR is the broadest and cheapest option, and its 2026 performance shows what happens when a factor is delivering, and a fund’s screen is loose. The fund returned 11% year-to-date and 26% over the trailing year, materially behind both AVUV and IJS, even though all three sit in the same Morningstar style box.
The reason is the index, as VBR tracks the CRSP US Small Cap Value Index, which uses a multifactor value definition but includes a wider range of names and a weaker profitability filter than either the Avantis methodology or the S&P 600. That dilutes the factor signal in a year when the signal is paying off. VBR is the right choice for investors who want low-cost small-cap value exposure as a permanent portfolio-building block rather than a tactical bet that the factor will work in the near term.
The tradeoff is straightforward: VBR offers the lowest holding cost and the broadest diversification of the three, but it gives up incremental return when the value premium is concentrated in the highest-quality, deepest-value names that the other two funds overweight.
Choosing Between the Three
The decision framework comes down to how much an investor believes in the factor. AVUV is the tool for investors who want the strongest possible academic tilt and are willing to pay an active expense ratio to get it. IJS is the middle path, lower-cost than AVUV, with a profitability screen baked into the index itself and a return profile that landed between the two in 2026. VBR is the lowest-cost, broadest exposure, suited to investors who treat small-cap value as a passive allocation rather than an active conviction.
All three deliberately step away from the Russell 2000 universe. The 2026 small-cap rally rewarded quality and value together, and the funds that screened hardest for both finished ahead.
Top Gaining Stocks
Top Losing Stocks